Protein Phosphatase 2A Holoenzyme Assembly

Protein Phosphatase 2A Holoenzyme Assembly

IDENTIFICATION OF CONTACTS BETWEEN B-FAMILY REGULATORY AND SCAFFOLDING A SUBUNITS*

Received for publication,March 27,2002,and in revised form,March 29,2002Published,JBC Papers in Press,April 2,2002,DOI 10.1074/jbc.M202992200

Stefan Strack?§,Ralf Ruediger ?,Gernot Walter ?,Ruben K.Dagda?,Chris A.Barwacz?,and J.Thomas Cribbs?

From the ?Department of Pharmacology,University of Iowa,Iowa City,Iowa 52242and ?Department of Pathology,University of California at San Diego,La Jolla,California 92093

Protein serine/threonine phosphatase (PP)2A is a ubiquitous enzyme with pleiotropic functions.Trimeric PP2A consists of a structural A subunit,a catalytic C subunit,and a variable regulatory subunit.Variable subunits (B,B ?,and B ?families)dictate PP2A substrate specificity and subcellular localization.B-family sub-units contain seven WD repeats predicted to fold into a ?-propeller structure.We carried out mutagenesis of B ?to identify domains important for association with A and C subunits in vivo .Several internal deletions in B ?abolished coimmunoprecipitation of A and C subunits expressed in COS-M6cells.In contrast,small N-and C-terminal B ?deletions had no effect on incorporation into the PP2A heterotrimer.Thus,holoenzyme associa-tion of B-family subunits requires multiple,precisely aligned contacts within a core ?-propeller domain.Charge-reversal mutagenesis of B ?identified a cluster of conserved critical residues in B ?WD repeats 3and 4.Acidic substitution of paired basic residues in B ?(RR165EE)abolished association with wild-type A and C subunits,while fostering incorporation of B ?into a PP2A heterotrimer containing an A subunit with an op-posite charge-reversal mutation (EE100RR).Thus,bind-ing of A and B subunits requires electrostatic interac-tions between conserved pairs of glutamates and arginines.By expressing complementary charge-rever-sal mutants in neuronal PC6-3cells,we further show that holoenzyme incorporation protects B ?from rapid degradation by the ubiquitin/proteasome pathway.

The balance of protein kinase and phosphatase activities toward key proteins is central to many aspects of cellular https://www.360docs.net/doc/2b7543283.html,pared with kinases,protein phosphatases have received little attention,and appreciation that they may be just as precisely regulated as the enzymes whose action they oppose is relatively recent.

PP2A 1is one of the four major classes of serine/threonine phosphatases that also include PP1,PP2B (calcineurin),and PP2C.PP2A is highly conserved in eukaryotes (for recent re-views,see Refs.1and 2).It constitutes between 0.3%and 1%of

total protein in mammalian cells (3,4)and supplies the major-ity of soluble phosphatase activity toward phospho-serine and -threonine.PP2A is a holoenzyme of two or three subunits.A 36-kDa catalytic or C subunit complexes with a 65-kDa scaf-folding A subunit to form the AC core enzyme;the core enzyme can bind a third,variable subunit to form the PP2A heterotri-mer.In mammals,A and C subunits are each encoded by two highly similar genes (A ?/?and C ?/?),with A ?and C ?isoforms being more abundant.Regulatory subunits are encoded by three multigene families referred to as B,B ?,and B ?.The B family (also known as PR55)consists of four genes,B ?,B ?,B ?,and B ?,that give rise to proteins with molecular masses of 54–57kDa (5–9).The B ?family (also referred to as B56or PR61)consists of at least seven isoforms encoded by five genes (B ??,B ??,B ??,B ??,and B ??)(10–15),with molecular masses between 54and 74kDa.The four known members of the B ?family are designated according to their masses as PR48(16),PR59(17),and PR72/130(18).Several PP2A regulatory sub-units show restricted tissue expression;for instance,B ?and B ?can only be detected in brain (6,19).Proteins encoded by DNA tumor viruses,SV40small t and polyoma virus small and middle T antigen,are a fourth group of proteins that bind to the PP2A core enzyme and subvert its activity as a suppressor of cellular transformation (20–22).The AC dimer has also been shown to interact with other proteins,including the WD re-peat-containing proteins striatin and SG2NA (23).

Evidence is accumulating that regulatory subunits impart specific functions to PP2A holoenzymes (24,25).For example,B-family regulatory subunits have been implicated in the reg-ulation of cytoskeletal protein assembly (26–28),B ?subunits participate in the developmental Wnt/?-catenin signal trans-duction cascade (29,30),and B ?subunits may control the G 1-S cell cycle transition (16,17).Adenovirus type 5appears to induce apoptosis by interaction of its E4orf4protein with the B ?subunit of PP2A (31,32).How regulatory subunits function to mediate the diverse physiological functions of PP2A is poorly understood.There is in vitro evidence that regulatory subunits affect enzymatic activity and substrate specificity of PP2A (33).Localization studies have suggested that regulatory subunits target PP2A holoenzymes to distinct subcellular compartments (11,14,19).

The crystal structure of the scaffolding A ?subunit of PP2A has been solved (34),confirming a previous model based on secondary structure prediction and mutagenesis studies (35).The A subunit is a hook-shaped protein made up almost en-tirely of 15imperfect repeats,each about 40amino acids long.Each of these HEAT repeats (named after proteins that contain them:h untingtin,e longation factor,A subunit,and T OR ki-nase)consists of two antiparallel,amphipathic ?-helices.Loops between the two helices (intrarepeat loops)form a continuous

*This work was supported by funds from the Department of Phar-macology and the Biosciences Initiative of the University of Iowa and by seed grants from the Diabetes and Endocrinology Research Center (DK25295)and the College of Medicine.The costs of publication of this article were defrayed in part by the payment of page charges.This article must therefore be hereby marked “advertisement ”in accordance with 18U.S.C.Section 1734solely to indicate this fact.

§To whom correspondence should be addressed:Dept.of Pharmacol-ogy,University of Iowa College of Medicine,2-432BSB,51Newton Rd.,Iowa City,IA 52242.Tel.:319-384-4439;Fax:319-335-8930;E-mail:stefan-strack@https://www.360docs.net/doc/2b7543283.html,.1

The abbreviation used is:PP,protein serine/threonine phosphatase.

T HE J OURNAL OF B IOLOGICAL C HEMISTRY

Vol.277,No.23,Issue of June 7,pp.20750–20755,2002

?2002by The American Society for Biochemistry and Molecular Biology,Inc.Printed in U.S.A.

This paper is available on line at https://www.360docs.net/doc/2b7543283.html,

20750

at Sun Yat-Sen University on November 18, 2007

https://www.360docs.net/doc/2b7543283.html,

Downloaded from

ridge along the inside of the hook,providing interaction sur-faces for catalytic and regulatory subunits.Regulatory sub-units and viral antigens bind to the 10N-terminal repeats,whereas the catalytic subunit binds via repeats 11–15(35,36).The PP2A C subunit is thought to have a roughly globular structure similar to that of the related PP1C subunit (37,38).Knowing how regulatory subunits fold and interact with the core PP2A dimer is crucial for our understanding of the diverse roles of PP2A in cells.Here,we carry out deletion and site-directed mutagenesis in combination with structure modeling to identify domains and amino acids important for holoenzyme association of B-family regulatory subunits.By complementary charge-reversal mutagenesis,we show that adjacent arginines in B ?critically interact with adjacent glutamates in the A ?subunit.

EXPERIMENTAL PROCEDURES

Structure Modeling—An amino acid alignment of B-family regula-tory subunits from different phyla was submitted to the 3D-PSSM protein fold recognition web server (39),which generated a first-round model based on the structure of the G ?1subunit of heterotrimeric G proteins (40).This model was globally and locally optimized for bond lengths,angles,and torsions of side chains using the steepest decent algorithm of the Swiss PDB Viewer software (41).In addition,breaks in the C ?trace were ligated with a cutoff value of 3.0?,and missing hydrogen atoms were added to the model.Ribbon diagrams and surface representations of the optimized B subunit model were rendered,an-notated,and analyzed using Rasmol and Swiss PDB Viewer software.Mutagenesis—The rat cDNA for B ?was isolated by reverse tran-scription-PCR from rat brain total RNA (Access reverse transcription-PCR kit;Promega,Madison,WI),subcloned into a pcDNA3.1mamma-lian expression vector under control of the cytomegalovirus promoter,and FLAG epitope tagged at the N terminus by PCR.

The B ??26–38and ?379–447mutants were generated by restric-tion digestion of the wild-type plasmid with uniquely cutting restriction enzymes,followed by fill-in and recircularization reactions.The B ??1–20N-terminal truncation mutant was generated by PCR amplifica-tion of the coding sequence with nested primers encoding the FLAG tag and amino acids 21–25of B ?.

Generation of internal deletion mutants involved PCR amplification of two halves of the B ?cDNA-containing plasmid,one extending from the 5?end of the deletion to approximately halfway around the plasmid,and the other extending from the 3?deletion boundary to the same site in the vector backbone in the opposite direction.Reverse primers an-nealing to sequences 5?of the deletion and forward primers annealing to 3?deletion boundaries also included a unique Sac II site encoding a neutral “stuffer ”sequence (Ala,Ala-Ala,or Ala-Ala-Gly),and comple-mentary forward and reverse primers annealing to the plasmid back-bone introduced a unique Asc I site.PCR-generated plasmid halves were digested with Sac II and Asc I and ligated to produce the complete plasmid carrying the deletion.

The B ??434–447and ?440–447C-terminal truncation mutants were generated by site-directed mutagenesis of residues 434and 440,respectively,to termination codons.Site-directed mutagenesis was car-ried out by whole-plasmid synthesis with complementary primers har-boring mutations utilizing Pfu Turbo polymerase (Stratagene),followed by destruction of the template plasmid by digestion with Dpn I.All mutations were verified by automated sequencing.All A ?subunit plas-mids have been described previously (42).

Transfection and Immunoprecipitation—COS-M6cells (43)were cul-tured in Dulbecco ’s modified Eagle ’s medium containing 10%fetal bo-vine serum and 4.5g/liter glucose and seeded into 6-well plates for transfection on the next day at ?80%confluence.Cells were transfected with 4?l of LipofectAMINE 2000(Invitrogen)and 2?g of plasmid DNA.A ?and B ?subunits plasmids were cotransfected at 1:1mass ratios.After 36–48h,cells were rinsed once with phosphate-buffered saline,lysed in 250?l/well immunoprecipitation buffer (1%Triton X-100,150m M NaCl,20m M Tris,pH 7.5,1m M EDTA,1m M EGTA,1m M ?-glycerolphosphate,1m M Na 3VO 4,1m M Na 4P 2O 7,1?M microcystin-LR,1m M phenylmethylsufonyl fluoride,1?g/ml leupeptin,and 1m M benzamidine),and sonicated for 2s at low intensity with a probe tip sonicator.Debris was pelleted (20,000?g ,15min),and FLAG-tagged B ?subunits were immunoprecipitated from the cleared lysate with 6?l of anti-FLAG tag antibody (M2)conjugated to agarose (Sigma)by end-over-end rotation at 4°C for 3–16h.In some experiments,200?g/ml

FLAG epitope peptide was added to the cleared lysate as a specificity control.Immunoprecipitates were washed with 6–8ml of immunopre-cipitation buffer and solubilized in SDS sample buffer for immunoblot analysis using the following antibodies:rabbit anti-FLAG tag (Affinity Bioreagents,Golden,CO),mouse anti-EE tag (Babco,Richmond,CA),mouse anti-PP2A catalytic subunit (BD PharMingen),and rabbit anti-ubiquitin (Novocastra,Newcastle,UK).Blots were processed for chemi-luminescence detection (Pierce SuperSignal,Pierce,New York,NY),and digital images were captured on a Kodak Imaging Station 440.Signal intensities were quantified by digital densitometry using Na-tional Institutes of Health Image software (https://www.360docs.net/doc/2b7543283.html,/nih-image/).

RESULTS AND DISCUSSION

Structure Prediction of PP2A B-family Regulatory Sub-units—Mammalian B-family regulatory PP2A subunits (B ?-?)display high degrees of sequence conservation (?80%amino acid identity).Secondary structure prediction suggests that B-family regulatory subunits are almost entirely composed of ?-sheets and turns,whereas the B ?and B ?subunits are mostly ?-helical.Thus,PP2A regulatory subunit families have distinct primary and secondary structures.As has been noted previ-ously (44),B-family regulatory subunits contain several degen-erate WD repeats (four to seven,depending on the isoform and motif search threshold).WD (also called WD40or G ?)repeats are loosely defined,?40-amino acid sequence motifs that often end with the tryptophan-aspartate (WD)dipeptide (45).The amino acid sequence of B ?,a representative member of the B subunit family,aligned by WD repeat motifs is shown in Fig.1A .Seven degenerate WD repeats are separated by regions of 13–46residues in length (c-d loops).

The two WD repeat-containing proteins whose three-dimen-sional structure has been solved to date are the G ?1subunit of heterotrimeric G proteins (40)and the p40subunit of the arp2/3actin filament branching complex (p40-ARC;Ref.46).Both proteins fold into a seven-bladed ?-propeller,a toroid structure in which seven twisted,antiparallel ?-sheets are radially arranged around a common center.Each WD repeat contributes the outer (d)?-strand of one propeller blade and the inner three ?-strands (a ?c)of the next propeller blade (Fig.1B ).This phase-shift of sequence and structural motifs allows for closure of the torus by a “velcro ”mechanism (45).Sequences preceding the first WD repeat and trailing the last repeat may protrude from the core toroid (Fig.1B ).

Three web-based threading protein fold prediction algo-rithms (3D-PSSM (39),FUGUE (47),and 123D (https://www.360docs.net/doc/2b7543283.html,/123D/123D.html))identified G ?1as the closest structural homolog of PP2A B-family regulatory subunits,de-spite low sequence similarity (?15%identity).The structure of B-family regulatory subunits was modeled based on the G ?1crystal structure (see “Experimental Procedures ”).A ribbon diagram of this model shows the seven-bladed ?-propeller fold characteristic of WD repeat-containing proteins (Fig.1C ).Be-cause PP2A B-family regulatory subunits are larger than G ?1,portions of the larger loops connecting WD repeats are missing from the model.

Deletion Mutagenesis—To define regions and residues in B-family regulatory subunits critical for association with the AC core dimer,we carried out deletion and site-directed mutagen-esis of the B ?coding sequence.Mutant B ?cDNAs carrying an N-terminal FLAG epitope tag were transiently expressed in COS-M6cells in combination with the scaffolding A ?subunit tagged with a C-terminal EE epitope (42).FLAG-B ?was im-munoprecipitated and washed extensively,and in vivo incor-poration into the PP2A heterotrimer was assayed by blotting B ?immunoprecipitates for transfected A ?and endogenous C subunits.The ability of B ?mutants to associate with the core enzyme was quantified by densitometry as the ratio of C to B ?subunit bands in the same lane.In general,mutating B ?af-

PP2A Holoenzyme Assembly

20751

at Sun Yat-Sen University on November 18, 2007

https://www.360docs.net/doc/2b7543283.html,

Downloaded from

fected A ?and C subunit binding to similar degrees,supporting the notion that regulatory subunits interact with a structural unit of A and C subunits.A schematic diagram of the B ?deletion and truncation mutants is shown in Fig.2A .

B subunit family members differ considerably in their first 20–30residues.Deletion of the variable 20N-terminal amino acids of B ?(?1–20)had little effect on binding to the A and

C subunit (Fig.2B ),consistent with a role of these residues in mediating isoform-specific functions.This deletion extends into the predicted first (d)?-strand of W

D repeat 1,which,accord-ing to the crystal structures of G ?1and p40-ARC,is critical for closure of the ?-propeller core by interacting with the c-strand of WD repeat 7(see Fig.1B ).It is conceivable that the FLAG epitope tag can substitute for the 5residues deleted from WD repeat 1;alternatively,the boundaries of this structural motif in B ?may require revision.

At the C terminus,truncating the 8amino acids that follow the last WD repeat in B ?(?440–447)had no effect on holoen-zyme association.Extending the truncation by just 6amino acids (?434–447)to include the predicted c-strand of WD re-peat 7caused an almost complete loss of A and C subunit binding.Thus,residues 434–439are required for holoenzyme association,presumably because they interact with N-terminal residues to maintain the toroid structure of B ?.

Four internal deletions throughout the B ?protein ranging from 12to 32residues in length completely abrogated coimmu-noprecipitation of A and C subunits (3–7%of wild-type);only the ?381–401deletion displayed close to wild-type binding activity (Fig.2B ).Three of these critical deletions (?128–156,?259–270,and ?370–401)are predicted to affect surface-ex-posed loops connecting WD repeats,whereas ?26–38deletes a portion of WD repeat 1predicted to be buried in the protein.The apparent intolerance of the B ?core (residues 21–439)to small deletions suggests that the interaction of B-family sub-units with the AC dimer requires precise alignment of multiple interacting residues.

Charge-reversal Mutagenesis —Site-directed mutagenesis was carried out to delineate specific sites of holoenzyme inter-action.All B ?residues that were mutated are perfectly con-served in other mammalian B-family isoforms and their or-

thologs in worms,fruit flies,and yeast.Carrying out similar mutagenesis experiments with the A ?subunit,we had previ-ously identified charged residues in HEAT repeats 3(Glu

100

F I

G .2.Mapping the holoenzyme association domains of B ?by deletion mutagenesis.Wild-type (w.t.)FLAG-tagged B ?,the dia-grammed deletion mutants (A ),or vector alone was transiently expressed in COS-M6cells,immunoprecipitated (IP ),and tested for association with cotransfected A ?subunit (EE epitope-tagged)and endogenous C subunit by immunoblotting.A representative immunoblot is shown in B ;the broad band below the A ?subunit band is immunoglobulin heavy chain.Coimmunoprecipitated C subunit (C coIP )was quantified as the ratio of C to B ?subunit in each lane and is listed relative to wild-type B ?below the blot (average of two to four independent

experiments).

F I

G .1.Structure prediction of B-family regulatory subunits.A ,the amino acid sequence of B ?was aligned according to boundaries of the seven WD repeats and component ?-strands (d and a ?c )provided by the Pfam web application (https://www.360docs.net/doc/2b7543283.html,;Ref.54).Sequence conservation of WD repeats is indicated by gray and black shading .B ,schematic of ?-strand arrangement of the ?-propeller fold,highlighting the phase-shift of WD repeats (identified by shading )and propeller blades.C ,ribbon view of the B subunit model based on the G ?1crystal structure;note that the large loops connecting WD repeats (c –d loops)were not completely modeled.

PP2A Holoenzyme Assembly

20752 at Sun Yat-Sen University on November 18, 2007

https://www.360docs.net/doc/2b7543283.html,

Downloaded from

and Glu 101)and 5(Arg 183)important for binding to regulatory subunits and viral tumor antigens (42).Hence,we focused the B ?mutagenesis on charge-reversal of basic and acidic residues with the goal of identifying electrostatic interactions with the A ?subunit.

Three acidic-to-basic mutations of conserved residues in the N-terminal third of B ?(E66R,EE89RR,and D112K)had no effect on holoenzyme association (Fig.3).In contrast,four B ?mutants in WD repeat 3(RR165EE,D184K,E186R,and DD192RR)and two mutants in the loop connecting WD repeat 3and WD repeat 4(D212K and IK213EE)displayed severely reduced binding to A and C subunits (between 2%and 12%of wild-type).Mapping to WD repeat 4,B ?mutant ED219RR incorporated into the PP2A holoenzyme normally,whereas E223R was defective.Because B ??259–270was binding-in-competent (Fig.2B ),we tested the effect of mutating all acidic residues in this region.B ?D259R did not bind to the AC dimer,whereas B ?EE266RR,E269R,and D270R had little or no effect on the ability of B ?to associate with A and C https://www.360docs.net/doc/2b7543283.html,stly,the E343R mutation in WD repeat 6had an interme-diate effect on the ability of B ?to incorporate into the PP2A heterotrimer (40%residual binding of the C subunit;Fig.3).The results of the deletion and site-directed mutagenesis experiments are summarized in Fig.3B .B ?mutants were classified as critical or noncritical depending on the amount of coimmunoprecipitated C subunit (?15%and ?40%of wild-type,respectively).Most critical amino acid substitutions clus-ter in the middle of the molecule (165–259)encompassing WD repeats 3and 4.

Li and Virshup (48)have recently reported that two frag-ments of B ??can bind to the A ?subunit in glutathione S -transferase pull-down assays.Intriguingly,the corresponding regions in B ?and B ?/PR72also interacted with A ?,even though PP2A regulatory subunit families display little primary amino acid similarity and are classified into different struc-tural families according to protein fold prediction algorithms

(39,47).The N-terminal “A subunit binding domain ”defined by Li and Virshup corresponds to B ?residues 172–270,a region that we show here contains many residues necessary for ho-loenzyme association in vivo .The C-terminal A subunit binding domain encompasses B ?residues 302–360.We mutated E343in this region,which,according to Li and Virshup ’s domain alignment (48),is invariant in B,B ?,B ?subunits,and we observed an intermediate effect on PP2A holoenzyme formation.

Identification of Interacting Residues —We speculated that evolutionarily conserved and surface-exposed,charged resi-dues of B ?interact with residues of opposite charge in A ?

that

F I

G .4.Identification of interacting residues in B ?and A ?.Wild-type (w.t.)or mutant FLAG-tagged B ?and EE-tagged A ?subunits were coexpressed in the indicated combinations in COS-M6cells and tested for association by FLAG immunoprecipitation,followed by im-munoblotting for PP2A

subunits.

F I

G .5.Ubiquitination and proteasome-mediated degradation of monomeric B ?subunits in PC6-3cells.A ,the indicated combi-nations of wild-type (w.t.)and mutant B ?and A ?subunits (ER,EE100RR)were transiently expressed in PC6-3cells,and total lysates were immunoblotted for B ?(FLAG tag)and the endogenous C subunit.B ,indicated B ?mutants or the ?isoform of calcium/calmodulin-depend-ent protein kinase II (CaMKII ?)were expressed in PC6-3cells and treated for 2h before lysis without (?)or with (?)the proteasome inhibitor MG-132(50?M ).Total lysates were immunoblotted for the indicated proteins.C ,FLAG-B ?D212K was transfected and immuno-precipitated from PC6-3cells treated for 6h in the absence or presence of 50?M MG-132.Aliquots of immunoprecipitates were blotted for the FLAG tag (left )and ubiquitin (right ).To account for increased levels of B ?after MG-132treatment,twice the volume of the control immuno-precipitate was analyzed.The distributions of high molecular weight FLAG tag and ubiquitin immunoreactivities do not correspond well because of the disproportion of ubiquitin and FLAG epitopes in larger B ?

species.

F I

G .3.Identification of B ?residues important for holoenzyme association.A ,wild-type (w.t.)FLAG-tagged B ?,the indicated site-directed mutants,or empty vector was expressed in COS-M6cells and tested for association with transfected A ?(EE-tagged)and endogenous C subunits by coimmunoprecipitation (coIP ).The percentage binding of the C subunit was quantified as described in the Fig.2legend and is shown as the average of two to five experiments.B ,summary of B ?deletion and site-directed mutagenesis results.Critical mutations dis-playing ?15%wild-type C subunit binding activity are indicated on the top of the domain diagram;noncritical mutations (?40%wild-type binding)are indicated on the bottom of the domain diagram.

PP2A Holoenzyme Assembly 20753

at Sun Yat-Sen University on November 18, 2007

https://www.360docs.net/doc/2b7543283.html,

Downloaded from

we previously identified as critical for regulatory subunit asso-ciation (Glu 100,Glu 101,and Arg 183;Ref.42).Consequently,we coexpressed charge-reversal mutants of the A ?subunit (EE100RR and R183E)with all opposite charge-reversal mu-tants of the B ?subunit and tested for complementation,i.e.restoration of holoenzyme assembly by coimmunoprecipitation.We were unable to show association of any of the acidic-to-basic mutants of B ?with the basic-to-acidic mutant A ?R183E (data not shown).There are three potential reasons for this:1)we may have not mutated the interacting residue in B ?,2)A ?or B ?mutations,while potentially affecting interacting residues,may introduce structural changes that misalign other impor-tant amino acids,and 3)A ?R183may not interact directly with regulatory subunits.

However,when we paired A ?EE100RR with B ?RR165EE,we observed binding that was comparable to wild-type subunits (Fig.4).B ?RR165EE was unable to coimmunoprecipitate an-other binding-defective,acidic-to-basic A ?mutant,DW139RR (data not shown),demonstrating that the observed complemen-tation is not a consequence of altering the overall charge of the proteins.Thus,PP2A holoenzyme association is critically de-pendent on electrostatic interactions between adjacent gluta-mates in the A subunit (Glu 100and Glu 101in A ?)and adjacent arginines in B-family regulatory subunits (Arg 165and Arg 166in B ?).Because the EE100RR mutation in A ?interferes with binding of all regulatory subunit families (42),it is likely that B ?and B ?subunits also interact via basic residues.We reversed the charge of a pair of conserved lysine residues in B ??that is in a position similar to B ?Arg 165and Arg 166(B ??KK173DD),but this mutation did not disrupt PP2A holoenzyme assembly (data not shown).Additional studies are necessary to identify points of contact between A ?and B ?/B ?subunits.

Monomeric B ?Is Degraded by the Ubiquitin /proteasome Pathway —All B ?mutants could be expressed to similar,high levels in COS-M6cells,a cell line that supports plasmid repli-cation due to expression of the SV40large T antigen.Studying the effects of B ?mutants in the neuronal PC6-3subline of PC12cells (49),in which much lower levels of expression can be achieved,we noticed that holoenzyme formation-defective mu-tants could be expressed to at most 10%of wild-type B ?levels.This is shown for two mutants in Fig.5A .Importantly,expres-sion levels of B ?RR165EE,but not D212K,could be rescued by coexpression of the complementary A ?EE100RR mutant,in-dicating that low expression is a consequence of failure to incorporate into the PP2A holoenzyme.To investigate the mechanism of this effect,PC6-3cells were treated with the proteasome inhibitor MG-132for 2h before immunoblotting.Proteasome inhibition resulted in a massive increase of B ?protein levels but had no effect on levels of another transfected protein (calcium/calmodulin-dependent protein kinase II ?)or the endogenous PP2A C subunit (Fig.5B ).MG-132treatment led to the accumulation of higher molecular weight species of B ?D212K that were immunoreactive for ubiquitin (Fig.5C ).Similar results were obtained with the RR165EE mutant and wild-type B ?.

It was previously shown that transfected B ?subunits quan-titatively incorporate into the PP2A holoenzyme (11)and that ablation of PP2A A or C subunits by RNA interference de-creases the stability of regulatory subunits in Drosophila Schneider cells (25).The present results provide further evi-dence that PP2A subunit expression levels are stringently con-trolled in cells and suggest ubiquitination and proteasome-mediated degradation as a mechanism for rapid removal of monomeric regulatory subunits.

Structure modeling and site-directed mutagenesis support the model of PP2A holoenzyme structure shown in Fig. 6.B-family regulatory subunits adopt a ?-propeller fold that is found in other proteins engaged in multiple

protein-protein

F I

G .6.Model of the PP2A holoenzyme.A space-filling representation of the structure of the A ?subunit (34)is arranged with model structures of the C and B ?subunits (based on the PP1catalytic subunit (38)and G ?1(40),respectively;see the text).Residues whose mutation disrupts subunit association (critical)are indicated in black ;interacting residues are colored green .Arg 183(R183)and Trp 257(W257)are highlighted as representative of several critical residues in HEAT repeats 5and 7of the A ?subunit (42).Some critical B ?residues are not shown because they are either absent from the model (Lys 214and Asp 259)or are buried (Asp 192).

PP2A Holoenzyme Assembly

20754 at Sun Yat-Sen University on November 18, 2007

https://www.360docs.net/doc/2b7543283.html,

Downloaded from

interactions (40,46).By mutational complementation,we iden-tified electrostatic interactions between two conserved argin-ines in the outer (d)strand of WD repeat 3of B ?and two glutamates in the intrarepeat loop of HEAT repeat 3of A ?.Previous domain mapping and site-directed mutagenesis of the A subunit (35,36,42)and the present data argue for multiple additional contacts between regulatory and scaffolding sub-units.Also,regulatory subunit binding to the AC dimer is likely stabilized by direct interactions between B and C sub-units,possibly involving the carboxyl-methylated C terminus of the C subunit (50–53).Critical amino acids in B ?are located C-terminal of the A subunit-contacting residues Arg 165and Arg 166and cluster in WD repeats 3and 4and the intervening loop.We propose that this region forms extensive contacts with the intrarepeat loops of HEAT repeats 4–7of the A ?subunit,where many residues important for regulatory subunit binding are localized (42).Consistent with possible isoform-specific functions,we find that the divergent N-terminal tail of B ?is expendable for intersubunit interactions.Instead,N-terminal residues of B-family regulatory subunits may determine the subcellular localization of PP2A holoenzymes by interacting with specific anchoring proteins (19).Compatible with this view,the B ?N terminus faces away from the A subunit in our PP2A holoenzyme model.This report addresses the structural basis of PP2A holoenzyme function but requires ultimate verification and refinement by other methods such as crystallography.

Acknowledgments —We thank Nancy Lill for advice on the protea-some experiments and gifts of MG-132and ubiquitin antibody,Henry Paulson for PC6-3cells,Raul Dagda for technical assistance,and John Koland for comments on the manuscript.

REFERENCES

1.Virshup,D.M.(2000)Curr.Opin.Cell Biol.12,180–185

2.Janssens,V.,and Goris,J.(2001)Biochem.J.353,417–439

3.Ruediger,R.,Van Wart Hood,J.E.,Mumby,M.,and Walter,G.(1991)Mol.

Cell.Biol.11,4282–4285

4.Lin,X.H.,Walter,J.,Scheidtmann,K.,Ohst,K.,Newport,J.,and Walter,G.

(1998)Proc.Natl.Acad.Sci.U.S.A.95,14693–14698

5.Healy,A.M.,Zolnierowicz,S.,Stapleton,A.E.,Goebl,M.,DePaoli-Roach,

A.A.,and Pringle,J.R.(1991)Mol.Cell.Biol.11,5767–5780

6.Mayer,R.E.,Hendrix,P.,Cron,P.,Matthies,R.,Stone,S.R.,Goris,J.,

Merlevede,W.,Hofsteenge,J.,and Hemmings,B.A.(1991)Biochemistry 30,3589–3597

7.Pallas,D.C.,Weller,W.,Jaspers,S.,Miller,T.B.,Lane,W.S.,and Roberts,

T.M.(1992)J.Virol.66,886–893

8.Zolnierowicz,S.,Csortos,C.,Bondor,J.,Verin,A.,Mumby,M.C.,and DePaoli-Roach,A.A.(1994)Biochemistry 33,11858–11867

9.Strack,S.,Chang,D.,Zaucha,J.A.,Colbran,R.J.,and Wadzinski,B.E.(1999)

FEBS Lett.460,462–466

10.McCright,B.,and Virshup,D.M.(1995)J.Biol.Chem.270,26123–2612811.McCright,B.,Rivers,A.M.,Audlin,S.,and Virshup,D.M.(1996)J.Biol.

Chem.271,22081–22089

12.Csortos,C.,Zolnierowicz,S.,Bako,E.,Durbin,S.D.,and DePaoli-Roach,A.A.

(1996)J.Biol.Chem.271,2578–2588

13.Tanabe,O.,Nagase,T.,Murakami,T.,Nozaki,H.,Usui,H.,Nishito,Y.,

Hayashi,H.,Kagamiyama,H.,and Takeda,M.(1996)FEBS Lett.379,107–111

14.Tehrani,M.A.,Mumby,M.C.,and Kamibayashi,C.(1996)J.Biol.Chem.271,

5164–5170

15.Zolnierowicz,S.,Van Hoof, C.,Andjelkovic,N.,Cron,P.,Stevens,I.,

Merlevede,W.,Goris,J.,and Hemmings,B.A.(1996)Biochem.J.317,187–194

16.Yan,Z.,Fedorov,S.A.,Mumby,M.C.,and Williams,R.S.(2000)Mol.Cell.Biol.20,1021–1029

17.Voorhoeve,P.M.,Hijmans,E.M.,and Bernards,R.(1999)Oncogene 18,515–524

18.Hendrix,P.,Mayer-Jackel,R.E.,Cron,P.,Goris,J.,Hofsteenge,J.,Merlevede,W.,and Hemmings,B.A.(1993)J.Biol.Chem.268,15267–15276

19.Strack,S.,Zaucha,J.A.,Ebner,F.F.,Colbran,R.J.,and Wadzinski,B.E.(1998)https://www.360docs.net/doc/2b7543283.html,p.Neurol.392,515–527

20.Pallas,D.C.,Shahrik,L.K.,Martin,B.L.,Jaspers,S.,Miller,T.B.,Brautigan,D.L.,and Roberts,T.M.(1990)Cell 60,167–176

21.Walter,G.,Ruediger,R.,Slaughter,C.,and Mumby,M.(1990)Proc.Natl.Acad.Sci.U.S.A.87,2521–2525

22.Sontag,E.,Fedorov,S.,Kamibayashi,C.,Robbins,D.,Cobb,M.,and Mumby,M.(1993)Cell 75,887–897

23.Moreno,C.S.,Park,S.,Nelson,K.,Ashby,D.,Hubalek,F.,Lane,W.S.,and Pallas,D.C.(2000)J.Biol.Chem.275,5257–5263

24.Zhao,Y.,Boguslawski,G.,Zitomer,R.S.,and DePaoli-Roach,A.A.(1997)J.Biol.Chem.272,8256–8262

25.Silverstein,A.M.,Barrow,C.A.,Davis,A.J.,and Mumby,M.C.(2002)Proc.Natl.Acad.Sci.U.S.A.99,4221–4226

26.Turowski,P.,Myles,T.,Hemmings,B.A.,Fernandez,A.,and Lamb,N.J.(1999)Mol.Biol.Cell 10,1997–2015

27.Sontag,E.,Nunbhakdi-Craig,V.,Bloom,G.S.,and Mumby,M.C.(1995)J.Cell Biol.128,1131–1144

28.Sontag,E.,Nunbhakdi-Craig,V.,Lee,G.,Bloom,G.S.,and Mumby,M.C.(1996)Neuron 17,1201–1207

29.Hsu,W.,Zeng,L.,and Costantini,F.(1999)J.Biol.Chem.274,3439–344530.Seeling,J.M.,Miller,J.R.,Gil,R.,Moon,R.T.,White,R.,and Virshup,D.M.(1999)Science 283,2089–2091

31.Kleinberger,T.(2000)Apoptosis 5,211–215

32.Branton,P.E.,and Roopchand,D.E.(2001)Oncogene 20,7855–7865

33.Kamibayashi,C.,Estes,R.,Lickteig,R.L.,Yang,S.I.,Craft,C.,and Mumby,M.C.(1994)J.Biol.Chem.269,20139–20148

34.Groves,M.R.,Hanlon,N.,Turowski,P.,Hemmings,B.A.,and Barford,D.(1999)Cell 96,99–110

35.Ruediger,R.,Hentz,M.,Fait,J.,Mumby,M.,and Walter,G.(1994)J.Virol.68,123–129

36.Ruediger,R.,Roeckel,D.,Fait,J.,Bergqvist,A.,Magnusson,G.,and Walter,G.(1992)Mol.Cell.Biol.12,4872–4882

37.Egloff,M.P.,Cohen,P.T.,Reinemer,P.,and Barford,D.(1995)J.Mol.Biol.254,942–959

38.Goldberg,J.,Huang,H.B.,Kwon,Y.G.,Greengard,P.,Nairn,A.C.,and Kuriyan,J.(1995)Nature 376,745–753

39.Kelley,L.A.,MacCallum,R.M.,and Sternberg,M.J.(2000)J.Mol.Biol.299,499–520

https://www.360docs.net/doc/2b7543283.html,mbright,D.G.,Sondek,J.,Bohm,A.,Skiba,N.P.,Hamm,H.E.,and Sigler,P.B.(1996)Nature 379,311–319

41.Guex,N.,and Peitsch,M.C.(1997)Electrophoresis 18,2714–272342.Ruediger,R.,Fields,K.,and Walter,G.(1999)J.Virol.73,839–842

43.Horowitz,M.,Cepko,C.L.,and Sharp,P.A.(1983)J.Mol.Appl.Genet.2,147–159

44.Griswold-Prenner,I.,Kamibayashi,C.,Maruoka,E.M.,Mumby,M.C.,and Derynck,R.(1998)Mol.Cell.Biol.18,6595–6604

45.Smith,T.F.,Gaitatzes,C.,Saxena,K.,and Neer,E.J.(1999)Trends Biochem.Sci.24,181–185

46.Robinson,R.C.,Turbedsky,K.,Kaiser,D.A.,Marchand,J.B.,Higgs,H.N.,Choe,S.,and Pollard,T.D.(2001)Science 294,1679–1684

47.Shi,J.,Blundell,T.L.,and Mizuguchi,K.(2001)J.Mol.Biol.310,243–25748.Li,X.,and Virshup,D.M.(2002)Eur.J.Biochem.269,546–552

49.Pittman,R.N.,Wang,S.,DiBenedetto,A.J.,and Mills,J.C.(1993)J.Neu-rosci.13,3669–3680

50.Wu,J.,Tolstykh,T.,Lee,J.,Boyd,K.,Stock,J.B.,and Broach,J.R.(2000)EMBO J.19,5672–5681

51.Tolstykh,T.,Lee,J.,Vafai,S.,and Stock,J.B.(2000)EMBO J.19,5682–569152.Yu,X.X.,Du,X.,Moreno,C.S.,Green,R.E.,Ogris,E.,Feng,Q.,Chou,L.,McQuoid,M.J.,and Pallas,D.C.(2001)Mol.Biol.Cell 12,185–199

53.Wei,H.,Ashby,D.G.,Moreno,C.S.,Ogris,E.,Yeong,F.M.,Corbett,A.H.,and Pallas,D.C.(2001)J.Biol.Chem.276,1570–1577

54.

Bateman,A.,Birney,E.,Cerruti,L.,Durbin,R.,Etwiller,L.,Eddy,S.R.,Griffiths-Jones,S.,Howe,K.L.,Marshall,M.,and Sonnhammer,E.L.(2002)Nucleic Acids Res.30,276–280

PP2A Holoenzyme Assembly

20755

at Sun Yat-Sen University on November 18, 2007

https://www.360docs.net/doc/2b7543283.html,

Downloaded from